328 related articles for article (PubMed ID: 2557900)
21. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
Obert B; Houllier A; Meyer D; Girma JP
Blood; 1999 Mar; 93(6):1959-68. PubMed ID: 10068669
[TBL] [Abstract][Full Text] [Related]
22. Binding of the von Willebrand factor A1 domain to histone.
Ward CM; Tetaz TJ; Andrews RK; Berndt MC
Thromb Res; 1997 Jun; 86(6):469-77. PubMed ID: 9219327
[TBL] [Abstract][Full Text] [Related]
23. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding.
Fujimura Y; Miyata S; Nishida S; Miura S; Kaneda M; Yoshioka A; Fukui H; Katayama M; Tuddenham EG; Usami Y
Thromb Haemost; 1992 Oct; 68(4):464-9. PubMed ID: 1280375
[TBL] [Abstract][Full Text] [Related]
24. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
Matsushita T; Sadler JE
J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
[TBL] [Abstract][Full Text] [Related]
25. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding.
Murata M; Ware J; Ruggeri ZM
J Biol Chem; 1991 Aug; 266(23):15474-80. PubMed ID: 1651333
[TBL] [Abstract][Full Text] [Related]
26. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
[TBL] [Abstract][Full Text] [Related]
27. Isolation and functional characterization of the von Willebrand factor-binding domain located between residues His1-Arg293 of the alpha-chain of glycoprotein Ib.
Vicente V; Kostel PJ; Ruggeri ZM
J Biol Chem; 1988 Dec; 263(34):18473-9. PubMed ID: 3263968
[TBL] [Abstract][Full Text] [Related]
28. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
[TBL] [Abstract][Full Text] [Related]
29. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
Murata M; Russell SR; Ruggeri ZM; Ware J
J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
[TBL] [Abstract][Full Text] [Related]
30. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet glycoprotein Ib monoclonal antibody (OP-F1) totally abolishes ristocetin-induced von Willebrand factor binding, but has minimal effect on the botrocetin-induced binding.
Nishio K; Fujimura Y; Nishida S; Takeda I; Yoshioka A; Fukui H; Tomiyama Y; Kurata Y
Haemostasis; 1991; 21(6):353-9. PubMed ID: 1823880
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
[TBL] [Abstract][Full Text] [Related]
33. von Willebrand factor mediates platelet spreading through glycoprotein Ib and alpha(IIb)beta3 in the presence of botrocetin and ristocetin, respectively.
McCarty OJ; Calaminus SD; Berndt MC; Machesky LM; Watson SP
J Thromb Haemost; 2006 Jun; 4(6):1367-78. PubMed ID: 16706984
[TBL] [Abstract][Full Text] [Related]
34. Structure and function of snake venom toxins interacting with human von Willebrand factor.
Matsui T; Hamako J
Toxicon; 2005 Jun; 45(8):1075-87. PubMed ID: 15922776
[TBL] [Abstract][Full Text] [Related]
35. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.
Matsui T; Hamako J; Matsushita T; Nakayama T; Fujimura Y; Titani K
Biochemistry; 2002 Jun; 41(25):7939-46. PubMed ID: 12069583
[TBL] [Abstract][Full Text] [Related]
36. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
37. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets.
Yoshida E; Fujimura Y; Miura S; Sugimoto M; Fukui H; Narita N; Usami Y; Suzuki M; Titani K
Biochem Biophys Res Commun; 1993 Mar; 191(3):1386-92. PubMed ID: 8466514
[TBL] [Abstract][Full Text] [Related]
38. Expression and characterization of functionally active fragments of the platelet glycoprotein (GP) Ib-IX complex in mammalian cells. Incorporation of GP Ib alpha into the cell surface membrane.
Meyer S; Kresbach G; Häring P; Schumpp-Vonach B; Clemetson KJ; Hadváry P; Steiner B
J Biol Chem; 1993 Sep; 268(27):20555-62. PubMed ID: 8376410
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of the von Willebrand factor modulator botrocetin.
Sen U; Vasudevan S; Subbarao G; McClintock RA; Celikel R; Ruggeri ZM; Varughese KI
Biochemistry; 2001 Jan; 40(2):345-52. PubMed ID: 11148028
[TBL] [Abstract][Full Text] [Related]
40. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane.
Berndt MC; Gregory C; Kabral A; Zola H; Fournier D; Castaldi PA
Eur J Biochem; 1985 Sep; 151(3):637-49. PubMed ID: 3161731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
